262 related articles for article (PubMed ID: 28270073)
21. Synthesis and bio-evaluation of xylan-5-fluorouracil-1-acetic acid conjugates as prodrugs for colon cancer treatment.
Sauraj ; Kumar SU; Gopinath P; Negi YS
Carbohydr Polym; 2017 Feb; 157():1442-1450. PubMed ID: 27987854
[TBL] [Abstract][Full Text] [Related]
22. Getting into the colon: approaches to target colorectal cancer.
Patel MM
Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic opportunities in colon-specific drug-delivery systems.
Patel M; Shah T; Amin A
Crit Rev Ther Drug Carrier Syst; 2007; 24(2):147-202. PubMed ID: 17725524
[TBL] [Abstract][Full Text] [Related]
24. Synergistic therapeutic effects of Schiff's base cross-linked injectable hydrogels for local co-delivery of metformin and 5-fluorouracil in a mouse colon carcinoma model.
Wu X; He C; Wu Y; Chen X
Biomaterials; 2016 Jan; 75():148-162. PubMed ID: 26497429
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents.
Sharma R; Rawal RK; Gaba T; Singla N; Malhotra M; Matharoo S; Bhardwaj TR
Bioorg Med Chem Lett; 2013 Oct; 23(19):5332-8. PubMed ID: 23968824
[TBL] [Abstract][Full Text] [Related]
26. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
27. Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics.
McCoubrey LE; Favaron A; Awad A; Orlu M; Gaisford S; Basit AW
J Control Release; 2023 Jan; 353():1107-1126. PubMed ID: 36528195
[TBL] [Abstract][Full Text] [Related]
28. Biorelevant dissolution testing of colon-specific delivery systems activated by colonic microflora.
Yang L
J Control Release; 2008 Jan; 125(2):77-86. PubMed ID: 18061301
[TBL] [Abstract][Full Text] [Related]
29. Colonic treatments and targets: issues and opportunities.
McConnell EL; Liu F; Basit AW
J Drug Target; 2009 Jun; 17(5):335-63. PubMed ID: 19555265
[TBL] [Abstract][Full Text] [Related]
30. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
31. Cutting-edge technologies in colon-targeted drug delivery systems.
Patel MM
Expert Opin Drug Deliv; 2011 Oct; 8(10):1247-58. PubMed ID: 21933030
[TBL] [Abstract][Full Text] [Related]
32. Microbially triggered drug delivery to the colon.
Sinha VR; Kumria R
Eur J Pharm Sci; 2003 Jan; 18(1):3-18. PubMed ID: 12554067
[TBL] [Abstract][Full Text] [Related]
33. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
Asghar LF; Chandran S
J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
[TBL] [Abstract][Full Text] [Related]
34. Colonic drug targeting.
Kinget R; Kalala W; Vervoort L; van den Mooter G
J Drug Target; 1998; 6(2):129-49. PubMed ID: 9886237
[TBL] [Abstract][Full Text] [Related]
35. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
Ma Y; Coombes AG
J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007
[TBL] [Abstract][Full Text] [Related]
36. Prodrugs of the cancer cell selective anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131) are orally efficacious in a mouse model of resistant colon cancer.
See CS; Kitagawa M; Liao PJ; Lee KH; Wong J; Lee SH; Dymock BW
Bioorg Med Chem Lett; 2019 Jan; 29(2):216-219. PubMed ID: 30503634
[TBL] [Abstract][Full Text] [Related]
37. Inulin as a Delivery Vehicle for Targeting Colon-Specific Cancer.
Chadha S; Kumar A; Srivastava SA; Behl T; Ranjan R
Curr Drug Deliv; 2020; 17(8):651-674. PubMed ID: 32459607
[TBL] [Abstract][Full Text] [Related]
38. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
[TBL] [Abstract][Full Text] [Related]
39. Pectin matrix as oral drug delivery vehicle for colon cancer treatment.
Wong TW; Colombo G; Sonvico F
AAPS PharmSciTech; 2011 Mar; 12(1):201-14. PubMed ID: 21194013
[TBL] [Abstract][Full Text] [Related]
40. Bacteria and pH-sensitive polysaccharide-polymer films for colon targeted delivery.
Esseku F; Adeyeye MC
Crit Rev Ther Drug Carrier Syst; 2011; 28(5):395-445. PubMed ID: 22077200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
